Furthermore, Lima et al. showed a significantly increased number of IL-17-positive cells in both lesional and perilesional HS skin when compared with healthy controls, with no difference in the number of IL-17-positive cells between perilesional and lesional HS skin. The gene discussed is IL17A; the disease is histiocytic sarcoma.